1.
Cost minimization analysis of generic and innovator formulations of metformin and its combination with other oral antidiabetic drugs. Int. J. of Res. in Pharmacology &Pharmacotherapeutics [Internet]. 2019 Oct. 14 [cited 2026 Jan. 14];8(4):481-7. Available from: https://ijrpp.com/ijrpp/article/view/453